Patents by Inventor Xiaojian Sun

Xiaojian Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WINDING, TRANSFORMER AND SWITCHING POWER SUPPLY
    Publication number: 20240128019
    Abstract: A winding includes one or more first magnetic poles, each has a first cross-sectional area equal to each other, and each is wound with a first primary side winding and a first secondary side winding. Each of the first primary side windings has a first number of primary side turns equal to each other, and each of the first secondary side windings has a first number of secondary side turns equal to each other. One or more second magnetic poles each have a second cross-sectional area equal to each other, and each is wound with a second primary side winding and a second secondary side winding. Each of the second primary side windings has a second number of primary side turns equal to each other, and each of the second secondary side windings has a second number of secondary side turns equal to each other.
    Type: Application
    Filed: October 11, 2023
    Publication date: April 18, 2024
    Inventors: Lanlan Yin, Yifeng Sun, Xiaojian Zhao
  • TIVOZANIB RESPONSE PREDICTION
    Publication number: 20140045715
    Abstract: A diagnostic method for predicting whether a human tumor will be sensitive or resistant to treatment with tivozanib (AV-951) is disclosed. The method is based on measurement of macrophage content in a tissue sample from a tumor. Measurement of macrophage content can be based on analysis of macrophage marker gene expression, e.g., by RNA analysis or immunohistochemistry.
    Type: Application
    Filed: August 5, 2013
    Publication date: February 13, 2014
    Applicant: AVEO PHARMACEUTICALS, INC.
    Inventors: Jie Lin, Bin Feng, Murray Robinson, Feng Jiang, Xiaojian Sun
  • TIVOZANIB AND CAPECITABINE COMBINATION THERAPY
    Publication number: 20120252829
    Abstract: A method of treating a tumor in a subject using a combination of tivozanib and capecitabine is disclosed.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 4, 2012
    Inventors: Jie Lin, Jeno Gyuris, Feng Jiang, Guangmu Li, Xiaojian Sun
  • TIVOZANIB RESPONSE PREDICTION
    Publication number: 20120231478
    Abstract: A diagnostic method for predicting whether a human tumor will be sensitive or resistant to treatment with tivozanib (AV-951) is disclosed. The method is based on measurement of macrophage content in a tissue sample from a tumor. Measurement of macrophage content can be based on analysis of macrophage marker gene expression, e.g., by RNA analysis or immunohistochemistry.
    Type: Application
    Filed: June 3, 2010
    Publication date: September 13, 2012
    Inventors: Jie Lin, Bin Feng, Murray Robinson, Feng Jiang, Xiaojian Sun
  • Tivozanib response prediction
    Patent number: 7736861
    Abstract: A diagnostic method for predicting whether a human tumor will be sensitive or resistant to treatment with tivozanib (AV-951) is disclosed. The method is based on measurement of macrophage content in a tissue sample from a tumor. Measurement of macrophage content can be based on analysis of macrophage marker gene expression, e.g., by RNA analysis or immunohistochemistry.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: June 15, 2010
    Assignee: AVEO Pharmaceuticals, Inc.
    Inventors: Jie Lin, Bin Feng, Murray Robinson, Feng Jiang, Xiaojian Sun